Childhood Cancer

You are here

Home » Grants » All grants tagged with "Acute Myeloid Leukemia (AML)"

All grants tagged with "Acute Myeloid Leukemia (AML)"

Dissecting the role and mechanism of MLLT10 fusion proteins to treat pediatric leukemia
Kathy Fange Liu, Ph.D.
The Trustees of the University of Pennsylvania
R Accelerated Award Grants, Awarded 2024
Targeting protein synthesis in pediatric acute myeloid leukemia
Courtney Jones, PhD
Cincinnati Children's Hospital Medical Center
'A' Award Grants, Awarded 2024
Development of allogeneic off-the-shelf gamma delta T cell product for pediatric AML
Norihiro Watanabe, PhD
Baylor College of Medicine
Innovation Grants, Awarded 2024
RAF Dimer Inhibitor Treatment in Pediatric Acute Myeloid Leukemia
Kevin Shannon, MD
The Regents of the University of California San Francisco
Innovation Grants, Awarded 2024
In vivo transdermal generation of CD33 CAR T-cells towards acute myeloid leukemia
Ruby Sims, PhD
University of California, Los Angeles
Young Investigator Grants, Awarded 2024
Cardiovascular comorbidities and cardiotoxicity as mechanisms for disparities in treatment outcomes for pediatric Acute Myeloid Leukemia
Emma Gombos
University of Pennsylvania
POST Program Grants, Awarded 2024
Acute myeloid leukemia; bloodstream infections and supportive care
Caleb Unterlack
Children’s Hospital of Philadelphia
POST Program Grants, Awarded 2024
Utilizing TIGIT-CAR natural killer cells to target acute myeloid leukemia
Kianna McEwen
Nationwide Children’s Hospital
POST Program Grants, Awarded 2024
Developing clinical guidance and improving care for AML-data abstraction
Nicolas Edgar
University of Utah
POST Program Grants, Awarded 2024
Therapeutic targeting of clonal hematopoiesis in RUNX1 mutant FPDMM
Robert Bowman, Ph.D.
University of Pennsylvania
RARE Grant Program (Research Accelerating RUNX1 Exploration), Awarded 2024

Pages

All childhood cancer types

Featured Hero

Seth Walsh

Seth is spunky and can be friends with anyone. After being diagnosed with ALL, Seth endured countless trips out-of-state, four relapses, two CAR T-cell therapies, two bone marrow transplants, and one clinical trial. Today, Seth has reached remission!
Read more »